米国のアフェレシス機器市場規模、シェア、動向分析レポート：製品別、用途別、施術別、技術別、セグメント別予測、2024年～2030年

米国のアフェレシス機器市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、米国のアフェレシス機器市場規模は2024年から2030年にかけてCAGR 8.6%で拡大し、2030年には16億4,000万米ドルに達すると予測されています。

アフェレシス技術の継続的な改善により、より効率的で使い勝手が良く、費用対効果の高い機器が開発されています。米国では腎不全、がん、自己免疫疾患などの慢性疾患の有病率が上昇しており、アフェレシス処置の需要が高まっています。例えば、国立医学図書館によると、2023年には米国で約1,958,310件の新たながん症例が観察されており、これがアフェレシス装置のニーズを後押ししています。

米国市場における新製品の発売は、機器に革新的な機能と技術の進歩をもたらし、効率、精度、性能を向上させる。規制当局の承認は、アフェレシス機器が安全性と有効性の基準を満たしていることを保証し、これは病院や診療所などのエンドユーザーにとって極めて重要です。例えば、血液・バイオ治療振興協会によると、2023年8月、テルモBCTはレビウス自動全血処理システムのFDA認可を取得しました。これは消費者の信頼を高め、市場の成長に貢献します。

米国のアフェレシス機器市場レポートハイライト

• 製品別では、使い捨てアフェレシスキットが2023年に70％以上のシェアを占め、市場を独占しました。これは、各キットが1回のみ使用され、その後廃棄されるため、患者間の交差汚染や感染伝播のリスクが排除されるという特徴によるものです。
• デバイス分野は、予測期間中に最も速いCAGRで成長すると予想されます。
• 用途別では、神経分野が2023年に最大の市場シェアを占めました。アフェレシスは、病気の原因となる抗体や免疫細胞を除去し、炎症を抑えて神経を保護するのに役立ちます。
• 米国のアフェレシス装置市場で事業を展開している市場プレーヤーには、Haemonetics Corporation、Fresenius Kabi、B. Braun SE、Mallinckrodt Pharmaceuticalsなどがあります。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国のアフェレシス機器市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 米国のアフェレシス機器市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国のアフェレシス機器市場：製品推定・動向分析

• 製品市場シェア、2023年および2030年
• セグメントダッシュボード
• 米国の成分分析装置市場：製品別展望
• 2018年から2030年までの市場規模と予測および動向分析
• ディスポーザブルアフェレシス機器
• デバイス

第5章 米国のアフェレシス機器市場：用途の推定・動向分析

• 用途市場シェア、2023年および2030年
• セグメントダッシュボード
• 米国の成分分析装置市場、用途別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 腎臓病
• 神経
• 血液
• その他

第6章 米国のアフェレシス機器市場：手順の推定・動向分析

• 手順の市場シェア、2023年と2030年
• セグメントダッシュボード
• 米国のアフェレシス機器市場：手順別展望
• 2018年から2030年までの市場規模と予測および動向分析
• フォトフェレシス
• プラズマフェレシス
• LDLアフェレシス
• 白血球アフェレシス
• 赤血球アフェレシス

第7章 米国のアフェレシス機器市場：技術の推定・動向分析

• テクノロジー市場シェア、2023年と2030年
• セグメントダッシュボード
• 技術展望による米国の成分分析装置市場
• 2018年から2030年までの市場規模と予測および動向分析
• 膜ろ過
• 遠心分離

第8章 米国のアフェレシス機器市場：地域の推定・動向分析

• 地域別市場シェア、2023年および2030年
• 地域別米国のアフェレシス機器市場の見通し
• 2018年から2030年までの市場規模と予測および動向分析
• 西部
• 中西部
• 北東部
• 南西部
• 南東部

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
• 企業プロファイル
  • Haemonetics Corporation
  • Fresenius Kabi
  • B. Braun SE
  • Mallinckrodt Pharmaceuticals
  • Nikkiso Co., Ltd.
  • Asahi Kasei Medical Co., Ltd.
  • Terumo BCT

List of Tables

• Table 1 List of abbreviations
• Table 2 U.S. apheresis equipment market, by product, 2018 - 2030 (USD Million)
• Table 3 U.S. apheresis equipment market, by application, 2018 - 2030 (USD Million)
• Table 4 U.S. apheresis equipment market, by procedure, 2018 - 2030 (USD Million)
• Table 5 U.S. apheresis equipment market, by technology, 2018 - 2030 (USD Million)
• Table 6 U.S. apheresis equipment market, by region, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 U.S. apheresis equipment market: market outlook
• Fig. 9 U.S. apheresis equipment competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 U.S. apheresis equipment market driver impact
• Fig. 14 U.S. apheresis equipment market restraint impact
• Fig. 15 U.S. apheresis equipment market: product movement analysis
• Fig. 16 U.S. apheresis equipment market: product outlook and key takeaways
• Fig. 17 Disposable apheresis kits market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 18 Device estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 U.S. apheresis equipment market: application movement Analysis
• Fig. 20 U.S. apheresis equipment market: application outlook and key takeaways
• Fig. 21 Renal disease market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Neurology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Hematology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 U.S. apheresis equipment market: procedure movement analysis
• Fig. 26 U.S. apheresis equipment market: procedure outlook and key takeaways
• Fig. 27 Photopheresis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Plasmapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 LDL apheresis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Plateletpheresis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Erythrocytapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Other market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 U.S. apheresis equipment market: technology movement analysis
• Fig. 35 U.S. apheresis equipment market: technology outlook and key takeaways
• Fig. 36 Membrane filtration market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Centrifugation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 U.S. apheresis equipment market: regional movement analysis
• Fig. 39 U.S. apheresis equipment market: regional outlook and key takeaways
• Fig. 40 West market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)

U.S. Apheresis Equipment Market Growth & Trends:

The U.S. apheresis equipment market size is anticipated to reach USD 1.64 billion by 2030, expanding at a CAGR of 8.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Continuous improvements in apheresis technology have led to the development of more efficient, user-friendly, and cost-effective equipment. The rise in the prevalence of chronic diseases in the U.S., such as kidney failure, cancer, and autoimmune disorders, has led to a higher demand for apheresis procedures. For instance, according to the National Library of Medicine, in 2023, approximately 1,958,310 new cancer cases were observed in the U.S., that in turn, drives the need for apheresis equipment.

New product launches in the U.S. market bring innovative features and technological advancements to the equipment, improving their efficiency, accuracy, and performance. Regulatory approvals ensure that the apheresis equipment meets safety and efficacy standards, which is crucial for the end-users, such as hospitals and clinics. For instance, according to the Association for the Advancement of Blood & Biotherapies, in August 2023, Terumo BCT received its FDA clearance for its Reveous Automated Whole Blood Processing System. This boosts consumer confidence and contributes to the growth of the market.

U.S. Apheresis Equipment Market Report Highlights:

• Based on product, disposable apheresis kits dominated the market with more than 70% share in 2023 owing to the feature of eliminating the risk of cross-contamination and infection transmission between patients, as each kit is used only once and then discarded
• The device segment is expected to grow at the fastest CAGR over the forecast period
• Based on application, the neurology segment held the largest market share in 2023. Apheresis helps to remove the disease-causing antibodies or immune cells, thus reducing inflammation and protecting the nerves
• Market players operating in the U.S. apheresis equipment market include Haemonetics Corporation, Fresenius Kabi, B. Braun SE, Mallinckrodt Pharmaceuticals

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Procedure
  • 1.2.4. Technology
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product
  • 2.2.2. Application
  • 2.2.3. Procedure
  • 2.2.4. Technology
• 2.3. Competitive Insights

Chapter 3. U.S. Apheresis Equipment Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. Apheresis Equipment Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Apheresis Equipment Market: Product Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. U.S. Apheresis Equipment Market by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
  • 4.4.1. Disposable Apheresis Kits
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Device
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Apheresis Equipment Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. U.S. Apheresis Equipment Market by Application Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
  • 5.4.1. Renal Disease
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Neurology
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Hematology
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Others
    • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Apheresis Equipment Market: Procedure Estimates & Trend Analysis

• 6.1. Procedure Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. U.S. Apheresis Equipment Market by Procedure Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
  • 6.4.1. Photopheresis
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 6.4.2. Plasmapheresis
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. LDL Apheresis
    • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Plateletpheresis
    • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Leukapheresis
    • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.6. Erythrocytapheresis
    • 6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.7. Others
    • 6.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. U.S. Apheresis Equipment Market: Technology Estimates & Trend Analysis

• 7.1. Technology Market Share, 2023 & 2030
• 7.2. Segment Dashboard
• 7.3. U.S. Apheresis Equipment Market by Technology Outlook
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
  • 7.4.1. Membrane Filtration
    • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 7.4.2. Centrifugation
    • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. U.S. Apheresis Equipment Market: Region Estimates & Trend Analysis

• 8.1. Regional Market Share, 2023 & 2030
• 8.2. U.S. Apheresis Equipment Market by Region Outlook
• 8.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
  • 8.3.1. West
    • 8.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 8.3.2. Midwest
    • 8.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.3. Northeast
    • 8.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.4. Southwest
    • 8.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.5. Southeast
    • 8.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company heat map analysis, 2023
• 9.4. Company Profiles
  • 9.4.1. Haemonetics Corporation
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Fresenius Kabi
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. B. Braun SE
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Mallinckrodt Pharmaceuticals
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Nikkiso Co., Ltd.
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Asahi Kasei Medical Co., Ltd.
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Terumo BCT
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives